Hemoptysis, the expectoration of blood originating from the respiratory tract, is a potentially life-threatening condition requiring rapid assessment and intervention in the ICU setting. Its prevalence and causes vary globally, reflecting differences between developed and developing countries. In developing nations, infectious diseases like tuberculosis are the most common causes of hemoptysis due to higher incidence rates and limited healthcare resources. Conversely, in developed countries, malignancies, bronchiectasis, and chronic inflammatory conditions are more prevalent etiologies [1].